<SEC-DOCUMENT>0001558370-24-006459-index.html : 20240502 <SEC-HEADER>0001558370-24-006459.hdr.sgml : 20240502 <ACCEPTANCE-DATETIME>20240502083020 ACCESSION NUMBER: 0001558370-24-006459 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240501 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLYCOMIMETICS INC CENTRAL INDEX KEY: 0001253689 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36177 FILM NUMBER: 24905479 BUSINESS ADDRESS: STREET 1: 9708 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-243-1201 MAIL ADDRESS: STREET 1: 9708 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>glyc-20240501x8k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: glyc-20240501x8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3.1 <SEQUENCE>2 <FILENAME>glyc-20240501xex3d1.htm <DESCRIPTION>EX-3.1 <TEXT> Document 2 - file: glyc-20240501xex3d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3.2 <SEQUENCE>3 <FILENAME>glyc-20240501xex3d2.htm <DESCRIPTION>EX-3.2 <TEXT> Document 3 - file: glyc-20240501xex3d2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>4 <FILENAME>glyc-20240501.xsd <DESCRIPTION>EX-101.SCH <TEXT> Document 4 - file: glyc-20240501.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>5 <FILENAME>glyc-20240501_lab.xml <DESCRIPTION>EX-101.LAB <TEXT> Document 5 - file: glyc-20240501_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>6 <FILENAME>glyc-20240501_pre.xml <DESCRIPTION>EX-101.PRE <TEXT> Document 6 - file: glyc-20240501_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>8 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 8 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>R2.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: R2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>10 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>12 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: FilingSummary.html
Document 14 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>16 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>17 <FILENAME>0001558370-24-006459-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 17 - file: 0001558370-24-006459-xbrl.zip
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>19 <FILENAME>glyc-20240501x8k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 19 - file: glyc-20240501x8k_htm.html
Document 19 - RAW XML: glyc-20240501x8k_htm.xml
</DOCUMENT> </SEC-DOCUMENT>